Hindustan Laboratories and RK Steel Set to Launch IPOs with SEBI Nod

Hindustan Laboratories and RK Steel Manufacturing Company have received SEBI approval to proceed with IPOs. Hindustan Laboratories plans a fresh issue and an offer for sale, while RK Steel's IPO is a fresh issue only. Proceeds will support working capital and corporate needs.

Hindustan Laboratories and RK Steel Manufacturing Company recently received approval from SEBI to move forward with their initial public offerings (IPOs), according to a regulatory update. Companies that submitted their draft IPO documents in September, and Hindustan Laboratories submitted the DRHP documents in January 2026, received observations from SEBI on April 27, which is tantamount to the green light to launch a public offering.

Hindustan Laboratories, an Indian pharmaceutical company specializing in the large-scale manufacturing and distribution of generic drugs to government bodies, plans a fresh issue of 50 lakh shares. The offering also includes an offer for the sale of 91 lakh shares by the promoters, as stated in the draft red herring prospectus (DRHP). The funds raised are earmarked for working capital and general corporate purposes.

In contrast, RK Steel Manufacturing Company's IPO constitutes solely a fresh issue of up to 2 crore equity shares, with no offer-for-sale component. The generated capital will be utilized for repaying or prepaying certain debts, as well as meeting working capital and corporate needs. Both companies expect their shares to be listed on the BSE and NSE.